Asset Type: Webinars, Imaging, Imaging Core Lab, Oncology

Centralized Imaging in Early Phase Oncology Trials

Oliver Bohnsack, MD, PhD, VP, Scientific & Medical Services, Head of Oncology

Amy Jung Hyun Lee, Ph.D, Sr. Project Manager

Centralized Imaging in Early Phase Oncology Trials

Our Perceptive Imaging scientists will review:

Operational benefits and key considerations when implementing central imaging in clinical studies.
Scientific considerations in early‑phase oncology and the critical role of BICR (Blind Independent Central Reading) in ensuring high‑quality, unbiased imaging data.
How BICR rolling reads enhance safety monitoring, particularly in studies with elevated risk of interstitial lung disease (ILD) in ADC drug.

Watch On-Demand

Name

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Business Email(Required)

Phone Number

Institute or Company(Required)

Service Line Interest(Required)

Therapeutic Area(Required)

I would like to subscribe to Perceptive marketing communications. By subscribing, you consent to receive emails from Perceptive. We respect your privacy, and you can manage your communication preferences anytime. You can find the Perceptive privacy policy.

Centralized Imaging in Early Phase Oncology Trials

Centralized Imaging in Early Phase Oncology Trials

Watch On-Demand

Stay Updated

Never miss a beat.